The chemical class designated as PCPTP1 Activators encompasses a diverse array of compounds that, through various mechanisms, can lead to the increased activity of Protein Tyrosine Phosphatase Receptor Type R (PCPTP1). These activators do not engage with PCPTP1 through direct binding as a substrate or allosteric modulator. Instead, they act upon different cellular signaling pathways that ultimately necessitate the upregulation of PCPTP1's phosphatase activity. The primary way these chemicals can activate PCPTP1 is by amplifying or attenuating signaling cascades within the cell, particularly those involving the MAPK pathway, which is a major regulatory target of PCPTP1. The MAPK pathway's role in regulating various cellular processes means that any modulation, whether it be enhancement or inhibition of the kinases within this pathway, can lead to a compensatory response that involves PCPTP1.
The activators in this class are varied in structure and function, originating from different chemical families and possessing distinct modes of action. Some are known to act as inhibitors or activators of enzymes that are upstream or downstream in the signaling pathways that intersect with PCPTP1's regulatory scope. Others may indirectly affect PCPTP1 activity by shifting the balance of phosphorylation within the cell, creating a context where PCPTP1 activity is upregulated to restore homeostasis. These compounds can influence the activity of kinases and phosphatases that play pivotal roles in cellular communication networks, effectively altering the demand on PCPTP1 to maintain the equilibrium of phosphorylation-dependent signaling. Through these intricate cellular feedback loops and regulatory mechanisms, the activity of PCPTP1 can be modulated without the compounds directly targeting the phosphatase itself. The breadth of this chemical class is a testament to the complex nature of intracellular signaling and the myriad ways that cellular enzyme activity can be regulated.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased intracellular cAMP levels. This increase in cAMP could possibly activate PCPTP1 by enhancing MAPK pathway activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can modulate the MAPK pathway. This modulation could possibly activate PCPTP1 to regulate the altered signaling. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates MAPK pathways such as JNK and p38. This activation could possibly activate PCPTP1 in a compensatory regulatory role. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Vanadate is a general inhibitor of tyrosine phosphatases. Its inhibitory action on other phosphatases could possibly activate PCPTP1 by altering phosphorylation dynamics. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases PP1 and PP2A. Inhibition of these phosphatases could possibly activate PCPTP1 by increasing phosphorylated MAPK levels. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
H2O2 is a reactive oxygen species that can affect signaling pathways, including MAPK signaling. This effect could possibly activate PCPTP1 as part of a signaling response. | ||||||